首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >Polymorphisms in the nuclear excision repair gene ERCC2/XPD and susceptibility to cutaneous basal cell carcinoma
【2h】

Polymorphisms in the nuclear excision repair gene ERCC2/XPD and susceptibility to cutaneous basal cell carcinoma

机译:核切除修复基因ERCC2 / XPD的多态性与皮肤基底细胞癌的易感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Studies have investigated the relationship between XPD Lys751Gln and Asp312Asn genetic variants and risk of cutaneous basal cell carcinoma (BCC). However, the results remain inconclusive. We performed a meta-analysis, using a comprehensive strategy based on the allele model and a model-free approach, to investigate the association of between XPD Lys751Gln and Asp312Asn polymorphisms with BCC risk. For XPD Lys751Gln, no significant BCC risk was found in the allele model (OR = 0.97, 95% CI 0.90-1.04, I 2 = 35.3%, P heterogeneity = 0.125) and with model-free approach (ORG = 0.95, 95% CI 0.87-1.04, I 2 = 15.9%, P heterogeneity = 0.296). For XPD Asp312Asn, there was also no association between this polymorphism and BCC risk in the allele model (OR = 0.94, 95% CI 0.86-1.03, I 2 = 0, P heterogeneity = 0.650) and with the model-free approach (ORG = 0.94, 95% CI 0.85-1.05, I 2 = 0, P heterogeneity = 0.603). Therefore, this meta-analysis suggests that the XPD Lys751Gln and Asp312Asn polymorphisms were not associated with BCC risk. Further large and well-designed studies are needed to confirm these findings.
机译:研究已经调查了XPD Lys751Gln和Asp312Asn遗传变异与皮肤基底细胞癌(BCC)风险之间的关系。但是,结果仍然不确定。我们使用基于等位基因模型和无模型方法的综合策略,进行了荟萃分析,以研究XPD Lys751Gln和Asp312Asn多态性与BCC风险之间的关系。对于XPD Lys751Gln,在等位基因模型中未发现明显的BCC风险(OR = 0.97,95%CI 0.90-1.04,I 2 = 35.3%,P异质性= 0.125),并且采用了无模型方法(ORG = 0.95,95%CI 0.87-1.04,I 2 = 15.9%,P异质性= 0.296)。对于XPD Asp312Asn,等位基因模型中的多态性与BCC风险之间也没有关联(OR = 0.94,95%CI 0.86-1.03,I 2 = 0,P异质性= 0.650),且与无模型方法(ORG = 0.94,95%CI 0.85-1.05,I 2 = 0,P异质性= 0.603)。因此,该荟萃分析表明XPD Lys751Gln和Asp312Asn多态性与BCC风险无关。需要进一步的大型且设计良好的研究来证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号